MDQK.HM jumps 200% to €7.50 on HAM 14 Jan 2026: oversold bounce trade setup

MDQK.HM stock jumped 200.00% to €7.50 on 14 Jan 2026 during the HAM regular session, a sharp intraday reversal from an open at €2.50. The move came on very low volume (35.00) versus an average of 41.00, signalling a low-liquidity bounce rather than broad buying. Traders should treat this as a short-term oversold bounce setup: price action and technical averages point to a volatile correction window. We examine fundamentals, technicals, Meyka AI grade and a practical trade plan for the Germany-listed MediNavi AG (MDQK.HM) in EUR.

MDQK.HM stock: Intraday price action and volume context

MediNavi AG (MDQK.HM) opened at €2.50 and printed a day low at €2.50 before spiking to a day high and year high of €7.50. The reported change was +€5.00 or +200.00% on 14 Jan 2026 during HAM trading in Germany. Volume remained 35.00, below the 50-day average 41.00, which suggests the jump was driven by limited orders and not broad institutional demand. For short-term traders the low relative volume raises the risk of a quick reversal back toward the prior trading range.

MDQK.HM stock: Fundamentals and key ratios

MediNavi AG lists limited public financials: EPS and PE are not available and no earnings announcement is on file. Key balance-sheet metrics show a current ratio 41.50 and a cash coverage ratio consistent with a cash-rich short-term position. Enterprise value over EBITDA is 2.17, while return on equity is negative at -0.07. These numbers imply a small-cap structure with atypical accounting metrics; absent robust revenue or EPS data, fundamentals provide only partial support for sustained gains.

MDQK.HM stock: Technicals and the oversold bounce view

Short-term technicals show a dramatic gap above the 50-day average (€2.50) and 200-day average (€2.00). Average true range is 5.00, reflecting large intraday swings. Classic oversold-bounce signals appear because the 50/200 averages were far below the spike, but RSI and many trend oscillators are unreliable here due to sparse data. In low-liquidity stocks, a large percentage move can prove transient; traders should confirm strength with follow-through volume before adding exposure.

Meyka grade and MDQK.HM stock model forecast

Meyka AI rates MDQK.HM with a score out of 100: 58.74 / C+ (HOLD). This grade factors S&P 500 and sector comparison, industry metrics, financial growth, key ratios and analyst signals. Meyka AI’s forecast model projects a 30-day fair value of €4.00, compared with the current price €7.50, implying an expected near-term move of -46.67% versus the intraday spike. Forecasts are model-based projections and not guarantees.

MDQK.HM stock: Trade plan, targets and risk controls

For an oversold-bounce strategy treat the move as a short-term trade. Concrete levels: short-term support near the open at €2.50, conservative re-entry target €3.00, and a cautious stop-loss at €2.50 to limit downside. A measured upside target for active traders is €12.00 (implied upside 60.00% from €7.50), but that requires clear volume confirmation. Given tiny liquidity, scale position sizes and prefer limit orders. No dividends or scheduled earnings appear in public filings, increasing event risk.

MDQK.HM stock: sector context and catalyst watch

MediNavi operates in Healthcare, specifically Medical – Healthcare Information Services. The German healthcare sector is trading modestly positive YTD at 2.53%, which gives a neutral backdrop for small-cap names. Key catalysts to monitor: any company update on platform adoption, regulatory notices, or secondary trades that raise free float. Check the company website for filings MediNavi and our coverage on the Meyka platform for real-time updates Meyka MDQK.HM page.

Final Thoughts

Key takeaways: MDQK.HM stock posted a 200.00% intraday surge to €7.50 on 14 Jan 2026 during HAM hours, but the move occurred on very low volume (35.00), below its 50-day average of 41.00. Fundamentals are thin — EPS and PE are not reported — though balance-sheet metrics show a high current ratio 41.50 and an enterprise value over EBITDA near 2.17. From a trade perspective this fits an oversold-bounce profile: the price jumped well above the 50-day and 200-day averages (€2.50 and €2.00) and may revert without confirming volume. Meyka AI’s model projects a 30-day fair value of €4.00, implying an implied downside of -46.67% versus the current spike; forecasts are model-based and not guarantees. If you trade this move, use small sizes, tight stops and monitor volume for confirmation. Meyka AI provides this as AI-powered market analysis and users should combine it with their own due diligence.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.